Eli Lilly Netherlands covid-19 pandemic crisis Eli Lilly Netherlands

Covid-19 pandemic: overcoming big pharma’s infectious disease market failure

Reading now: 509
www.pharmaceutical-technology.com

The Covid-19 pandemic has taken the world completely by surprise. The pharmaceutical industry has stepped up to try and find solutions to the escalating global crisis, which has tragically killed more than 370,000 people.

However, the fact that most companies are having to start from scratch in tackling Covid-19 highlights how unprepared the industry was and big pharma’s weakness in the infectious disease space.

A recent exclusive story revealed that major European pharma companies, including Johnson & Johnson, Pfizer, Eli Lilly and GlaxoSmithKline, refused to engage in preparatory work to accelerate vaccine development in advance of possible outbreaks.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA